New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Tilray Brands, Inc.
TLRY
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

609M

Drug Manufacturers - Specialty & Generic

Next Earning date - 08 Apr 2025

609M

Drug Manufacturers - Specialty & Generic

Next Earning date - 08 Apr 2025

0.65USD

Shape0.00 ( 0.23%)
Market Closed (as of Mar 21, 20:00 EDT)
favorite-chart

Relative Strenght

5
favorite-chart

Volume Buzz

-26%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

78%

Quote Panel

Shape
Updated March 24, 2025
1W -3.80 % 1M -19.45 % 3M -56.08 % 1Y -69.77 %

Key Metrics

Shape
  • Market Cap

    609.48M


  • Shares Outstanding

    937.66M


  • Share in Float

    931.58M


  • Dividende

    0


  • Earning Date

    08 Apr 2025


  • Price Target

    0.65


  • Average Volume

    44.38M


  • Beta

    2.037


  • Range

    0.58-2.97


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.tilray.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

TLRY

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$894M

Shape324%

2025-Revenue

$0.27

Shape-170%

2025-EPS

$350M

Shape-745%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Hold

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

Canaccord Genuity

upgrade

Previous: Not converted

2022-03-05

Now: Buy

Cantor Fitzgerald

upgrade

Previous: Not converted

2021-06-10

Now: Overweight

Jefferies

upgrade

Previous: Not converted

2021-05-09

Now: Market Outperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

N/A

-0.04
vs 0.04

Q2.23

arrow
arrow

N/A

-0.15
vs -0.34

Q3.23

arrow
arrow

N/A

-0.10
vs -0.08

Q4.23

arrow
arrow

N/A

-0.07
vs -0.06

Q1.24

arrow
arrow

N/A

-0.12
vs -0.04

Q2.24

arrow
arrow

N/A

-0.04
vs -0.15

Q3.24

arrow
arrow

N/A

-0.04
vs -0.10

Q4.24

arrow
arrow

N/A

-0.10
vs -0.07

Q1.25

arrow
arrow

N/A

-0.06
vs -0.12

Q2.25

arrow
arrow

N/A

-0.03
vs -0.04

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

-4%

145.6M  vs 151.9M

Q2.23

arrow
arrow

+20%

184.2M  vs 153.3M

Q3.23

arrow
arrow

+15%

176.9M  vs 153.2M

Q4.23

arrow
arrow

+34%

193.8M  vs 144.1M

Q1.24

arrow
arrow

+29%

188.3M  vs 145.6M

Q2.24

arrow
arrow

+25%

229.9M  vs 184.2M

Q3.24

arrow
arrow

+13%

200M  vs 176.9M

Q4.24

arrow
arrow

+9%

210.9M  vs 193.8M

Q1.25

arrow
arrow

+12%

211.6M  vs 188.3M

Q2.25

arrow
arrow

+18%

272.1M  vs 229.9M

Return on EquityShape

status-upQoQ

Q1.23

arrow
arrow

-35%

-0.35
vs -0.02

Q2.23

arrow
arrow

-4%

-0.04
vs -0.35

Q3.23

arrow
arrow

-2%

-0.02
vs -0.04

Q4.23

arrow
arrow

-1%

-0.01
vs -0.02

Q1.24

arrow
arrow

-3%

-0.03
vs -0.01

Q2.24

arrow
arrow

-1%

-0.01
vs -0.03

Q3.24

arrow
arrow

-1%

-0.01
vs -0.01

Q4.24

arrow
arrow

-2%

-0.02
vs -0.01

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

364

364
vs 387

-6%

Q2.23

arrow
arrow

356

356
vs 364

-2%

Q3.23

arrow
arrow

376

376
vs 356

6%

Q4.23

arrow
arrow

376

376
vs 376

NA

Q1.24

arrow
arrow

380

380
vs 376

1%

Q2.24

arrow
arrow

373

373
vs 380

-2%

Q3.24

arrow
arrow

370

370
vs 373

-1%

Q4.24

arrow
arrow

365

365
vs 370

-1%

Earnings Growth

Latest News

TLRY

seekingalpha.com

11 hours ago